FDA product code OZE: Influenza A And Influenza B Multiplex Nucleic Acid Assay

OZE is the FDA product code for influenza a and influenza b multiplex nucleic acid assay. It is a Class II device, regulated under 21 CFR 866.3980 and reviewed by the Microbiology panel. FDA has cleared 21 510(k) submissions under OZE, 6 in the last five years, from 9 different applicants. The average 510(k) review took 72 days (median 32); 78 days on average over the last three years. FDA has posted 5 recalls for OZE devices, 4 initiated in the last five years.

Definition

An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and discrimination of influenza A and B nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract influenza viral infections if used in conjunction with other clinical and laboratory findings.

Classification

FieldValue
Device nameInfluenza A And Influenza B Multiplex Nucleic Acid Assay
Device classClass II
Regulation21 CFR 866.3980
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for OZE

YearClearancesAvg. review days
2017129
20182138
20193102
2020125
2022198
2023132
2024129
20252176
2026130

Compare with all 510(k) review times · Search every OZE clearance

Top OZE applicants

ApplicantClearancesLatest
Centers for Disease Control and Prevention102026-09-30
Centers For Disease Control and Prevention (CDC)32018-07-30
Quidel Corp.22013-08-29
Quidel Corporation12023-03-03
Abbott Diagnostics Scarborough, Inc.12022-06-24

4 more applicants have OZE clearances. See the full list in Caduvo.

Most recent OZE clearances

510(k)ApplicantDeviceDecision dateReview days
K263035Centers for Disease Control and PreventionCDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel (includes Influenza A/B Typing Kit, Influenza A Subtyping Kit, Influenza A(H5) Subtyping Kit, and Influenza B Lineage Genotyping Kit)2026-09-3030
K243274Centers for Disease Control and PreventionCDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4)2025-07-11268
K243931Centers for Disease Control and PreventionCDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A Subtyping Kit (VER 4); Influenza B Lineage Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4)2025-03-1484
K241110Centers for Disease Control and PreventionCDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4)2024-05-2129
K230236Quidel CorporationLyra Influenza A+B Assay2023-03-0332

Recalls for OZE devices

5 product recalls in 5 recall events; 4 initiated in the last five years and 4 still open. Most recent: 2026-02-09.

YearRecalls
20191
20241
20252
20261

Frequently asked questions

What is FDA product code OZE?

OZE is the FDA product code for influenza a and influenza b multiplex nucleic acid assay. It is a Class II device, regulated under 21 CFR 866.3980 and reviewed by the Microbiology panel.

What device class is OZE?

Class II, regulation 21 CFR 866.3980. Typical premarket route: 510(k).

How long does a 510(k) take for product code OZE?

Across 21 cleared submissions the average was 72 days from receipt to decision (median 32).

Which companies have the most OZE clearances?

Centers for Disease Control and Prevention (10); Centers For Disease Control and Prevention (CDC) (3); Quidel Corp. (2); Quidel Corporation (1); Abbott Diagnostics Scarborough, Inc. (1).

Have OZE devices been recalled?

Yes: 5 product recalls across 5 recall events; the most recent began 2026-02-09.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times